Our data demonstrate that these effects are an indirect consequence of IL-22-mediated expansion of IS-derived BC followed by their re-differentiation to yield IS hyperplasia and provide insights into mechanisms of protection against secondary bacterial pneumonia after respiratory viral infection. This evidence concerns the gene IL22 and breast cancer.